Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellectis (CLLS) EBT: 2015-2023

Historic EBT for Cellectis (CLLS) over the last 9 years, with Sep 2023 value amounting to -$14.1 million.

  • Cellectis' EBT rose 39.55% to -$14.1 million in Q3 2023 from the same period last year, while for Sep 2023 it was -$40.4 million, marking a year-over-year increase of 24.24%. This contributed to the annual value of -$80.8 million for FY2022, which is 141.85% down from last year.
  • According to the latest figures from Q3 2023, Cellectis' EBT is -$14.1 million, which was down 555.30% from $3.1 million recorded in Q2 2023.
  • Over the past 5 years, Cellectis' EBT peaked at $14.4 million during Q1 2020, and registered a low of -$42.4 million during Q3 2021.
  • For the 3-year period, Cellectis' EBT averaged around -$16.9 million, with its median value being -$14.1 million (2023).
  • As far as peak fluctuations go, Cellectis' EBT spiked by 162.34% in 2020, and later tumbled by 183.93% in 2021.
  • Cellectis' EBT (Quarterly) stood at -$38.5 million in 2019, then dropped by 1.74% to -$39.2 million in 2020, then surged by 79.39% to -$8.1 million in 2021, then tumbled by 47.88% to -$11.9 million in 2022, then surged by 39.55% to -$14.1 million in 2023.
  • Its last three reported values are -$14.1 million in Q3 2023, $3.1 million for Q2 2023, and -$17.5 million during Q1 2023.